Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation
RVI after HCT, particularly those caused by RSV, PIV-3, and influenza, increase the risk of pulmonary impairment and mortality. These infections should be targeted for specific anti-viral approaches and intensified monitoring for late onset pulmonary disease.
Authors
- Keith R. Jerome (ORCID: https://orcid.org/0000-0002-8212-3789)
- Paul A. Carpenter (ORCID: https://orcid.org/0000-0002-5021-0714)
- Hu Xie (ORCID: https://orcid.org/0000-0003-0556-6591)
- Chikara Ogimi (ORCID: https://orcid.org/0000-0002-2166-8152)
- Michael Boeckh (ORCID: https://orcid.org/0000-0003-1538-7984)
- Jason W. Chien (ORCID: https://orcid.org/0009-0005-4296-5171)
- Alpana Waghmare (ORCID: https://orcid.org/0000-0003-2268-9470)
- Cheryl Callais
- Lawrence Corey (ORCID: https://orcid.org/0000-0002-2179-2436)
- Jane Kuypers (ORCID: https://orcid.org/0000-0002-0189-0274)
- Wendy M. Leisenring (ORCID: https://orcid.org/0000-0001-7405-0906)
- Janet A. Englund (ORCID: https://orcid.org/0000-0003-1134-4178)
- Terry Stevens‐Ayers (ORCID: https://orcid.org/0000-0002-7546-8439)
- Brenda M. Sandmaier (ORCID: https://orcid.org/0000-0002-9767-9739)
- Angela P. Campbell (ORCID: https://orcid.org/0000-0002-2576-482X)
- Guang‐Shing Cheng (ORCID: https://orcid.org/0000-0003-4324-9634)
- W. Garrett Nichols
Institutions
- Seattle Children's Hospital (US)
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- Seattle Children's Hospital (US)
- Center for Cancer and Blood Disorders (US)
- University of Washington Applied Physics Laboratory (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-09-27
- DOI
- https://doi.org/10.1093/infdis/jiaf503
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00